GLS-3000
/ Houston Methodist Hospital, GeneOne
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
May 29, 2020
GLS-1200Topical Nasal Spray to Prevent SARS-CoV-2 Infection (COVID-19) in Health Care Personnel
(clinicaltrials.gov)
- P2; N=225; Not yet recruiting; Sponsor: GeneOne Life Science, Inc.
Clinical • New P2 trial • Infectious Disease • Novel Coronavirus Disease
1 to 1
Of
1
Go to page
1